Evelyn Zeira

Title: **Evelyn Zeira: Innovator in Mucosal Immunization**

Introduction

Evelyn Zeira is a prominent inventor based in Beit-Shemesh, Israel, recognized for his groundbreaking work in the field of immunization. With a focus on innovative medical solutions, Zeira's contributions are notable in the realm of vaccine administration, particularly for the hepatitis A virus (HAV).

Latest Patents

Zeira holds a patent for a method of mucosal immunization against hepatitis A virus through rectal administration of the HAV vaccine. This innovative approach allows the HAV vaccine to be effectively absorbed through mucosal tissue, specifically the rectum, overcoming traditional administration methods that often require injections and needles. By providing alternatives like suppositories or rectal dosage forms, his invention significantly enhances the ease and accessibility of immunization.

Career Highlights

Throughout his career, Evelyn Zeira has been associated with Hadasit Medical Research Services and Development Ltd., contributing to various research and development projects aimed at improving health outcomes. His work reflects a commitment to enhancing medical practices and patient experiences.

Collaborations

Zeira collaborates with talented professionals such as Mali Ketzinel Gilad and Hilla Giladi, among others. Together, they work towards advancing medical technologies and pushing the boundaries of traditional therapeutic methods in immunization.

Conclusion

Evelyn Zeira exemplifies the spirit of innovation in healthcare through his patent for a novel method of administering the hepatitis A vaccine. His contributions not only pave the way for more efficient immunization techniques but also demonstrate the vital role of inventors in shaping the future of medicine.